Funding
← Back to your selection

Temasek

Activity from announced rounds

Activity in this selectionSeries C+

Temasek is a Singapore investment company with global public and private holdings, investing around digitisation, sustainable living, the future of consumption and longer lifespans.

Its global direct investments target both emerging and established market leaders. The four structural themes cut across industries: AI and computing, renewable energy and industrial decarbonisation, changing consumer demand and health-related innovation.

Temasek’s portfolio also includes Singapore-based companies and partnerships with fund managers. Since April 2026, its organisational structure separates global direct investments, Singapore holdings and partnership solutions, giving these distinct investment activities dedicated teams.

Sources
Rounds participated in
6
Confirmed lead rounds
2
3 roles undisclosed
New companies
6
First participation on record · 0 follow-on
Funding in participating rounds
$4.3B
5 disclosed · full round size, not this investor’s share

By stage

Series C+6

By primary sector

AI1
Climate tech1
Hardware1
Healthtech1
Mobility1
1 more
Space tech1

By country

United States3
India1
Netherlands1
United Kingdom1

Rounds

6 in this selection
Devoted Health

Devoted Health brings Medicare Advantage coverage together with medical care, virtual visits, in-home services and Member Service Guides for older adults.

$555MSeries G
Lead
The Boring Company

The Boring Company builds tunnel-boring machines and underground Loop passenger systems for cities and transport partners.

$3BSeries D
Participant
Pixxel

Hyperspectral Earth-observation satellites and software that turn spectral imagery into operational intelligence.

$100MSeries C
Lead
Nearfield Instruments

Develops advanced 3D scanning probe metrology and inspection systems for semiconductor manufacturing

$380MSeries D
Role not disclosed
PhysicsX

Builds AI-native engineering simulation software compressing months of design work into seconds for manufacturing and defence

$300MSeries C
Role not disclosed